Peanut (Ara h 6) IgE Test · Blood

If you or your child has ever had a worrying reaction to peanuts, or a routine allergy test came back positive for peanut, the next question is the one that actually matters: are you truly allergic, or just sensitized without real-world risk? A standard peanut IgE test cannot always answer that question with confidence. Ara h 6 IgE (immunoglobulin E directed at one of peanut's main storage proteins) can help.

Ara h 6 is one of two peanut proteins that drive most severe peanut reactions. A blood test for IgE against this specific protein helps separate real allergy from harmless cross-reactivity, and in many studies it performs as well as the better-known Ara h 2 test. For families weighing food challenges, schools, restaurants, and emergency plans, that distinction is the entire game.

What This Test Actually Measures

This is a blood test for IgE antibodies (a class of immune protein your body makes when it mistakes a harmless substance for a threat) that specifically bind to Ara h 6. Ara h 6 is a small storage protein found in peanuts. It is closely related to another peanut protein called Ara h 2, and the two together are responsible for most serious peanut reactions.

When you have IgE against Ara h 6, your immune system has been primed to react to peanut. Your body makes this antibody mostly in tissues exposed to food, including the lining of your gut, where specialized immune cells called B cells switch to producing IgE after repeated peanut exposure. Once that IgE is in circulation, eating peanut can trigger the cascade that leads to hives, swelling, vomiting, or anaphylaxis.

Ara h 6 IgE is what scientists call a component test, meaning it isolates one specific peanut protein rather than measuring antibodies against everything in a peanut. This is why it tends to be more specific than the whole-peanut IgE test. A positive result is a stronger signal that real allergy exists.

Why Whole-Peanut IgE Often Falls Short

Whole-peanut IgE testing throws everything in the peanut into one assay. Some of those proteins cross-react with pollens, especially birch pollen, which means people who have hay fever can test positive for peanut without ever being at real risk of a serious reaction. The result is a lot of false alarms, unnecessary peanut avoidance, and anxiety.

Component testing helps fix this. In Japanese children, Ara h 6 IgE distinguished true allergy with an AUC of roughly 0.82 (a measure of how well a test separates two groups, where 1.0 is perfect and 0.5 is a coin flip), compared with a much lower AUC for whole-peanut IgE. In UK children, Ara h 6 IgE performed similarly to Ara h 2, with high sensitivity and specificity at standard cutoffs. Whole-peanut testing does not perform at that level.

How It Compares to Ara h 2

Ara h 2 IgE is the more famous component test, and in most labs it is the default. Ara h 6 is its close cousin, and across populations the two perform almost identically. In adults, Ara h 6 IgE had an AUC of 0.82 versus Ara h 2 at a similar value. In Mediterranean children, both performed comparably with high diagnostic accuracy.

The catch is that the two tests do not always agree at the individual level. In studies of adults and children, a small but real subset of people are positive for Ara h 6 but negative for Ara h 2, or the reverse. Relying on Ara h 2 alone can miss a meaningful share of cases in some cohorts. A case series identified children with Ara h 6 mono-sensitization who had moderate to severe reactions on challenge. If you order only Ara h 2 and it comes back negative, you may be reassured for the wrong reason.

Combining the two improves accuracy. In Mediterranean children, requiring both Ara h 2 and Ara h 6 to be positive gave 77% sensitivity and 97% specificity, with a high positive predictive value and negative predictive value.

What the Number Says About Reaction Severity

Higher Ara h 6 IgE generally tracks with higher probability of an allergic reaction during an oral food challenge. In Japanese children, a model estimated about 95% probability of any allergic reaction at high Ara h 6 IgE levels. Co-sensitization to both Ara h 2 and Ara h 6 has been linked to more severe reactions at lower doses of peanut in challenge studies.

That said, no single blood number reliably predicts anaphylaxis. The 2020 peanut allergy practice parameter, a major guideline document, explicitly cautions against using component IgE levels to forecast how severe a future reaction will be. The test tells you whether you are likely to react. It does not tell you how badly.

Reconciling the Two Findings

This is the kind of nuance that trips people up. Higher Ara h 6 IgE is associated with greater reaction probability and, in groups of patients, with more severe outcomes. But at the individual level, your specific number cannot forecast your specific worst-case reaction. The reason: severity depends on many factors beyond IgE level, including the quality of your IgE (which epitopes it binds), how reactive your mast cells and basophils are, what else you ate that day, whether you have asthma, and how much peanut you consumed. Ara h 6 IgE is one important input. It is not a crystal ball.

What Ara h 6 IgE Tells You During Immunotherapy

If you or your child is undergoing peanut oral immunotherapy (gradually escalating doses of peanut to train the immune system to tolerate it), Ara h 6 IgE typically falls and a protective antibody called IgG4 rises. The ratio of IgG4 to IgE shifts in a favorable direction. This change correlates with how much peanut someone can ingest without reacting and is one of the cleanest biological signals that desensitization is working.

However, baseline Ara h 6 IgE alone does not predict who will respond to immunotherapy. In the PALISADE trial, screening levels of Ara h 6 IgE and IgG4 did not forecast treatment outcome. The test is useful for tracking the immune response over time, not for picking responders ahead of time.

Why One Reading Is Not Enough

A single Ara h 6 IgE result is a snapshot. Levels can change with age, with peanut exposure (or strict avoidance), and during immunotherapy. In children, peanut allergy resolves naturally in roughly one-third of cases by age 10, and falling component IgE levels over years are one of the signals that resolution may be underway. A child whose Ara h 6 IgE has dropped steadily over time has a different risk profile than one whose level is rising or stable.

For anyone with a peanut diagnosis or under observation, get a baseline now, then retest annually at minimum. If you are doing oral immunotherapy or trying a structured reintroduction, retest at 3 to 6 month intervals to track whether your immune system is shifting. A single high number in isolation tells you less than a trajectory.

When Results Can Be Misleading

A few things can throw off the interpretation of a single Ara h 6 IgE test.

• Low-positive zone: levels in the low range overlap between truly allergic and merely sensitized people. A faintly positive result is not definitive proof of allergy.
• Sensitization without allergy: you can have detectable IgE against Ara h 6 and still tolerate peanut. Sensitization is a lab finding. Allergy is a clinical event. The two are related but not identical.
• Negative does not always mean safe: rare patients react to peanut despite very low specific IgE. If your history strongly suggests allergy and your blood tests are negative, a basophil activation test or supervised oral food challenge may still be warranted.
• Test variability: different assay platforms (ImmunoCAP, ALEX2, microarray) can report different numbers for the same sample. Trend your results on the same platform when possible.

What to Do With an Out-of-Pattern Result

A clearly positive Ara h 6 IgE in someone with a history of peanut reactions confirms the diagnosis and reinforces the need for strict avoidance, an epinephrine auto-injector, and an action plan. A clearly negative Ara h 6 IgE in someone with no history of reactions makes true allergy unlikely, though it does not absolutely exclude it.

Patterns that warrant further workup include: a positive Ara h 6 with a negative Ara h 2 (or vice versa) in someone with a convincing history, which suggests mono-sensitization and should prompt evaluation by an allergist; a positive component test in someone who has never knowingly eaten peanut, where supervised oral food challenge may be the only way to resolve the ambiguity; and a falling Ara h 6 IgE over years in a previously diagnosed child, which may justify discussing reintroduction with a specialist. A basophil activation test is a useful tiebreaker in equivocal cases. Pair Ara h 6 with Ara h 2 and a skin prick test for the most complete picture, and involve a board-certified allergist for any decision about peanut introduction, challenge, or immunotherapy.